Theralase Technologies Inc. V.TLT

RE:RE:RE:RE:RE:Great News

[Pandora]

enriquesuave wrote: I don't think we were told which category of patients were the 3 who were already retreated (2nd treatment). with the non-optimized procedure.  We specifically told that from now on the 5 patients awaiting 2nd treatment and all new patients will be treated with optimized procedure.  Will take time, but we should see major improvement I sure hope.  IMO 

From the newsletter:

Of the 7 patients, who demonstrated a Response to the Study Treatment defined as negative cystoscopy i.e.(no evidence of cancer in their bladders)

or negative urine cytology i.e.(no evidence of urothelial carcinoma cells in their urine) at 90 days post initial treatment:

43% (3 patients) achieved a 'Complete Response' (“CR”) -- (negative cystoscopy and negative urine cytology).

43% (3 patients) achieved a 'Response' -- (negative cystoscopy and positive or suspicious cytology)

14% (1 patient) achieved a 'Response' -- (suspicious cystoscopy and negative cytology)

"Of the 8 patients eligible to receive the second treatment in Study II, three patients have received their second treatment, four patients are awaiting second treatment, subject to clinical study site operating room availability, and "one patient" - Patient #8 not referred to in any way in the foregoing is undergoing additional assessments prior to proceeding to second treatment."

I guess you could say that the above statement does not definitely say that the 3 patients that first received the second treatment were actually identified as the 3 that demonstrated "Complete Response" but to me it would seem only natural. ??